We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$291M
AUM Growth
+$8.49M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 89.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$227M 77.84%
10,719,400
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$34M 11.67%
2,818,835
INDA icon
3
iShares MSCI India ETF
INDA
$6.71B
$15.6M 5.35%
320,000
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$15M 5.14%
400,000

Similar funds

Meditor Group's Q3 2021 Portfolio in Review

As of Q3 2021, Meditor Group held 4 positions worth $291M, up 3% from $283M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 90% a quarter earlier.

  • Meditor Group's ten largest holdings make up 100% of its $291M portfolio in Q3 2021.
  • Meditor Group opened 0 new positions and closed 0 in Q3 2021.
  • Meditor Group's portfolio value rose 3% quarter-over-quarter to $291M.

Based on Meditor Group's 13F filing for Q3 2021, filed 14 Oct 2021.